Home » Stocks » IsoRay

IsoRay, Inc. (ISR)

Stock Price: $0.400 USD 0.000 (0.00%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $0.401 +0.001 (0.25%) Oct 21, 4:50 PM

Stock Price Chart

Key Info

Market Cap 27.56M
Revenue (ttm) 9.68M
Net Income (ttm) -3.45M
Shares Out 68.90M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $0.400
Previous Close $0.400
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.412
Day's Range 0.390 - 0.430
Day's Volume 1,803,253
52-Week Range 0.288 - 1.060

More Stats

Market Cap 27.56M
Enterprise Value 25.99M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 68.90M
Float 68.01M
EPS (basic) -0.05
EPS (diluted) -0.05
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.31M
Short Ratio 3.22
Short % of Float 1.93%
Beta 1.93
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.85
PB Ratio 6.92
Revenue 9.68M
Operating Income -3.48M
Net Income -3.45M
Free Cash Flow -3.91M
Net Cash 1.57M
Net Cash / Share 0.02
Gross Margin 52.93%
Operating Margin -35.91%
Profit Margin -35.70%
FCF Margin -40.43%
ROA -23.98%
ROE -51.42%
ROIC -64.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$1.28*
(220.00% upside)
Low
1.00
Current: $0.400
High
1.60
Target: 1.28
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue9.687.315.924.764.774.614.224.535.075.24
Revenue Growth32.35%23.48%24.41%-0.17%3.54%9.17%-6.76%-10.76%-3.2%-
Gross Profit5.123.051.840.840.130.17-0.200.150.701.16
Operating Income-3.48-5.25-6.73-6.31-5.08-4.34-4.59-4.07-3.60-2.96
Net Income-3.45-5.14-6.70-6.16-4.71-3.68-5.96-3.86-3.49-2.84
Shares Outstanding67.6067.0455.1655.0255.0254.8842.6834.4228.6225.13
Earnings Per Share-0.05-0.08-0.12-0.11-0.09-0.07-0.16-0.11-0.12-0.11
Operating Cash Flow-3.64-5.05-5.71-5.71-3.88-3.52-3.23-3.06-2.45-2.42
Capital Expenditures-0.27-0.41-0.34-0.54-0.48-0.13-0.02-0.01-0.06-0.14
Free Cash Flow-3.91-5.46-6.05-6.26-4.36-3.66-3.25-3.06-2.50-2.56
Cash & Equivalents2.575.513.619.1515.5419.8823.273.082.852.29
Total Debt1.01---------
Net Cash / Debt1.575.513.619.1515.5419.8823.273.082.852.29
Assets8.709.427.4612.2718.1023.0026.557.067.517.89
Liabilities2.981.742.431.671.702.222.591.691.691.44
Book Value5.727.685.0310.6016.4020.7823.965.375.826.45
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name IsoRay, Inc.
Country United States
Employees 53
CEO Lori A. Woods

Stock Information

Ticker Symbol ISR
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSEAMERICAN: ISR

Description

Isoray, through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.